Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Avid Bioservices Inc (CDMO)

Avid Bioservices Inc (CDMO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 286,251
  • Shares Outstanding, K 56,238
  • Annual Sales, $ 53,600 K
  • Annual Income, $ -4,220 K
  • 60-Month Beta 2.69
  • Price/Sales 5.41
  • Price/Cash Flow N/A
  • Price/Book 5.76

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 10/31/19
See More
  • Average Estimate -0.04
  • Number of Estimates 3
  • High Estimate -0.02
  • Low Estimate -0.07
  • Prior Year -0.06
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.97 +2.51%
on 10/16/19
5.55 -8.29%
on 10/21/19
-0.22 (-4.14%)
since 10/11/19
3-Month
4.89 +4.00%
on 09/11/19
7.15 -28.81%
on 09/05/19
-1.39 (-21.45%)
since 08/09/19
52-Week
3.37 +51.04%
on 05/20/19
7.15 -28.81%
on 09/05/19
+0.07 (+1.39%)
since 11/09/18

Most Recent Stories

More News
New Strong Sell Stocks for November 7th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

BCPC : 103.19 (-0.24%)
BERY : 42.08 (+0.38%)
GLW : 29.94 (-1.42%)
BXMT : 36.02 (+0.08%)
CDMO : 5.09 (-1.36%)
Avid Bioservices Names Richard Richieri as Chief Operations Officer

Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development...

CDMO : 5.09 (-1.36%)
CDMOP : 26.50 (+1.88%)
Avid Bioservices Announces Completion of Expansion of Process Development Capabilities and Laboratory Infrastructure

Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services...

CDMO : 5.09 (-1.36%)
CDMOP : 26.50 (+1.88%)
New Strong Sell Stocks for October 8th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

AIRYY : 18.8400 (-2.33%)
BASFY : 19.4500 (-0.71%)
CIR : 42.10 (-0.40%)
CDMO : 5.09 (-1.36%)
ICMB : 6.83 (+0.44%)
Why Avid Bioservices (CDMO) Could Be Positioned for a Slump

Avid Bioservices (CDMO) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

ANIK : 60.23 (+0.02%)
CDMO : 5.09 (-1.36%)
Avid Bioservices Announces Termination of Stockholder Rights Plan

Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services...

CDMO : 5.09 (-1.36%)
CDMOP : 26.50 (+1.88%)
Avid Bioservices (CDMO) Reports Q1 Loss, Tops Revenue Estimates

Avid Bioservices (CDMO) delivered earnings and revenue surprises of -166.67% and 5.56%, respectively, for the quarter ended July 2019. Do the numbers hold clues to what lies ahead for the stock?

CDMO : 5.09 (-1.36%)
Avid Bioservices Reports Financial Results for First Quarter Fiscal 2020 and Recent Developments

-- Achieved First Quarter Revenue of $15.3 Million; Reaffirms Fiscal 2020 Projected Revenue of $64 to $67 Million --

CDMO : 5.09 (-1.36%)
CDMOP : 26.50 (+1.88%)
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services...

CDMO : 5.09 (-1.36%)
CDMOP : 26.50 (+1.88%)
Avid Bioservices to Report Financial Results For First Quarter of Fiscal Year 2020 After Market Close on September 5, 2019

Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services...

CDMO : 5.09 (-1.36%)
CDMOP : 26.50 (+1.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade CDMO with:

Business Summary

Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture. The company provides process development, high quality cGMP clinical and commercial manufacturing...

See More

Key Turning Points

2nd Resistance Point 5.25
1st Resistance Point 5.17
Last Price 5.09
1st Support Level 5.03
2nd Support Level 4.97

See More

52-Week High 7.15
Fibonacci 61.8% 5.71
Fibonacci 50% 5.26
Last Price 5.09
Fibonacci 38.2% 4.81
52-Week Low 3.37

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar